10-K Filing

WORLD HEALTH ENERGY HOLDINGS, INC. CIK: 943535 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001493152-21-008940`
Period End Date	20201231
Filing Date	20210415
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	when-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 18 Cash Flow Statement 42 Stockholders Equity 11

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$359.46K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$359.95K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	5.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$6.45K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	5.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$5.09K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	5.00M	shares	Point-in-time
Other current assets (Note 3)	`OtherAssetsCurrent`	$42.18K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets (Note 3)	`OtherAssetsCurrent`	$213.01K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	110.00B	shares	Point-in-time
Total Current assets	`AssetsCurrent`	$578.92K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	750.00B	shares	Point-in-time
Total Current assets	`AssetsCurrent`	$407.21K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	110.00B	shares	Point-in-time
Right Of Use asset arising from operating lease	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	89.79B	shares	Point-in-time
Right Of Use asset arising from operating lease	`OperatingLeaseRightOfUseAsset`	$24.03K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	0.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	0.00	shares	Point-in-time
Long term loans and prepaid expenses (Note 6)	`OtherAssetsNoncurrent`	$24.88K	USD	Point-in-time
Long term loans and prepaid expenses (Note 6)	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	89.79B	shares	Point-in-time
Property and Equipment, Net (Note 4)	`PropertyPlantAndEquipmentNet`	$26.05K	USD	Point-in-time
Property and Equipment, Net (Note 4)	`PropertyPlantAndEquipmentNet`	$17.23K	USD	Point-in-time
Total assets	`Assets`	$620.18K	USD	Point-in-time
Total assets	`Assets`	$458.15K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$26.28K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$31.37K	USD	Point-in-time
Other account liabilities (Note 5)	`OtherAccruedLiabilitiesCurrent`	$496.87K	USD	Point-in-time
Other account liabilities (Note 5)	`OtherAccruedLiabilitiesCurrent`	$73.48K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$104.85K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$523.16K	USD	Point-in-time
Liability for employee rights upon retirement	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$41.85K	USD	Point-in-time
Liability for employee rights upon retirement	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$104.85K	USD	Point-in-time
Long term loan from parent company	`DueToRelatedPartiesNoncurrent`	$1.10M	USD	Point-in-time
Long term loan from parent company	`DueToRelatedPartiesNoncurrent`	$1.81M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.44M	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	$3.50K	USD	Point-in-time
Common stock, par $0.0007, 110,000,000,000 shares authorized, 89,789,407,996 and 0 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively.	`CommonStockValue`	-	USD	Point-in-time
Common stock, par $0.0007, 110,000,000,000 shares authorized, 89,789,407,996 and 0 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively.	`CommonStockValue`	$62.85M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$-2.68K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$-63.34M	USD	Point-in-time
Foreign currency translation adjustments	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$-5.50K	USD	Point-in-time
Foreign currency translation adjustments	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$-5.50K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-623.84K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.50M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-629.31K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-203.80K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.98M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$620.18K	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$458.15K	USD	Point-in-time

Income Statement 18 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$98.16K	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$103.95K	USD	Annual
Research and development expenses (Note 8)	`ResearchAndDevelopmentExpense`	$489.21K	USD	Annual
Research and development expenses (Note 8)	`ResearchAndDevelopmentExpense`	$263.53K	USD	Annual
General and administrative expenses (Note 9)	`GeneralAndAdministrativeExpense`	$226.54K	USD	Annual
General and administrative expenses (Note 9)	`GeneralAndAdministrativeExpense`	$523.66K	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-914.71K	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-386.12K	USD	Annual
Financing income (expenses), net	`OtherNonoperatingIncomeExpense`	$-27.81K	USD	Annual
Financing income (expenses), net	`OtherNonoperatingIncomeExpense`	$41.92K	USD	Annual
Net loss	`NetIncomeLoss`	$-872.79K	USD	Annual
Net loss	`NetIncomeLoss`	$-413.93K	USD	Annual
Other comprehensive loss - Foreign currency loss	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	Annual
Other comprehensive loss - Foreign currency loss	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-11.59K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-872.79K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-425.51K	USD	Annual
Loss per common stock (basic and diluted)	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Loss per common stock (basic and diluted)	`EarningsPerShareBasicAndDiluted`	-	USD	Annual

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`NetIncomeLoss`	$-872.79K	USD	Annual
Net loss for the period	`NetIncomeLoss`	$-413.93K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$39.44K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$38.71K	USD	Annual
Increase in liability for employee rights upon retirement	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$22.94K	USD	Annual
Increase in liability for employee rights upon retirement	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$63.00K	USD	Annual
Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.36K	USD	Annual
Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-4.78K	USD	Annual
Decrease (increase) in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$9.88K	USD	Annual
Decrease (increase) in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$5.97K	USD	Annual
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$23.66K	USD	Annual
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.08K	USD	Annual
Increase in other accounts liabilities	`IncreaseDecreaseInAccruedLiabilities`	$130.48K	USD	Annual
Increase in other accounts liabilities	`IncreaseDecreaseInAccruedLiabilities`	$15.46K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-318.26K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-649.56K	USD	Annual
Loans granted to related parties	`PaymentsToFundLongtermLoansToRelatedParties`	$232.18K	USD	Annual
Loans granted to related parties	`PaymentsToFundLongtermLoansToRelatedParties`	$80.22K	USD	Annual
Increase in other long term prepaid expenses	`IncreaseInOtherLongTermPrepaidExpenses`	-	USD	Annual
Increase in other long term prepaid expenses	`IncreaseInOtherLongTermPrepaidExpenses`	$24.88K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$24.23K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.44K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-281.29K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-81.67K	USD	Annual
Payments of lease liability	`FinanceLeasePrincipalPayments`	$29.17K	USD	Annual
Payments of lease liability	`FinanceLeasePrincipalPayments`	$27.92K	USD	Annual
Loan received from parent company	`ProceedsFromRelatedPartyDebt`	$960.51K	USD	Annual
Loan received from parent company	`ProceedsFromRelatedPartyDebt`	$766.12K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$931.34K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$738.20K	USD	Annual
EFFECT OF EXCHANGE RATES ON CASH AND CASH EQUIVALENTS	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Annual
EFFECT OF EXCHANGE RATES ON CASH AND CASH EQUIVALENTS	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-1.96K	USD	Annual
INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$336.31K	USD	Annual
INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$488.00	USD	Annual
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$359.95K	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.15K	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$359.46K	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$359.95K	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.15K	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$359.46K	USD	Point-in-time
Debt set off	`NotesAssumed1`	$250.61K	USD	Annual
Debt set off	`NotesAssumed1`	-	USD	Annual

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-629.31K	USD	Point-in-time
Balance	`StockholdersEquity`	$-203.80K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.98M	USD	Point-in-time
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-11.59K	USD	Annual
Effect of Reverse Capitalization (Note 1 B)	`EffectOfReverseCapitalizationValue`	$-480.46K	USD	Annual
Net loss for the period	`NetIncomeLoss`	$-872.79K	USD	Annual
Net loss for the period	`NetIncomeLoss`	$-413.93K	USD	Annual
Balance	`StockholdersEquity`	$-629.31K	USD	Point-in-time
Balance	`StockholdersEquity`	$-203.80K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.98M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.